Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions
in leucine-rich repeat kinase 2 (LRRK2). By sequencing multiplex families consistent with …

Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

Objective The Lrrk2 kinase domain G2019S substitution is the most common genetic basis
of familial and sporadic parkinsonism. Patients harboring the G2019S substitution usually …

Several pathogenic mutations in the leucine‐rich repeat kinase 2 (LRRK2; PARK8) gene
recently have been identified in familial and sporadic parkinsonism. We screened 435 …

Importance Substantial genome-wide association study (GWAS) work in Parkinson disease (PD)
has led to the discovery of an increasing number of loci shown reliably to be associated …

A rare variant in TREM2 (p.R47H, rs75932628) was recently reported to increase the risk of
Alzheimer's disease (AD) and, subsequently, other neurodegenerative diseases, ie …

Parkinson’s disease is a genetically complex disorder. Multiple genes have been shown to
contribute to the risk of Parkinson’s disease, and currently 90 independent risk variants have …

The MAPT H1 haplotype has been associated with four-repeat (4R) tauopathies, including
progressive supranuclear palsy, corticobasal degeneration, and argyrophilic grain disease. …

Genealogical investigation of a large Norwegian family (F04) with autosomal dominant
parkinsonism has identified 18 affected family members over four generations. Genetic studies …